NewBridge Pharmaceuticals
@nbpharma.com
Founded in 2010, NewBridge Pharmaceuticals is a specialty pharmaceutical company committed to improving patient access to innovative therapies across the Middle East and Africa. Through strategic partnerships with leading global pharmaceutical and biotechnology companies, we bring transformative healthcare innovations to the region, addressing critical unmet medical needs and enhancing patient outcomes. Our strategic focus spans Oncology, Hematology, Immunology, Neuroscience, Metabolic Diseases, and Rare Diseases. Through a combination of regional expertise, strong market access capabilities, and excellence in commercial, regulatory, and medical affairs, we help bring life-changing therapies to patients across the region. Backed by experienced leadership and strong institutional investors, NewBridge has established itself as a trusted partner of choice for pharmaceutical and biotechnology companies seeking to expand their presence across the MENA region.
NewBridge Pharmaceuticals's Company Logos
NewBridge Pharmaceuticals's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#8C8532
Sycamore
140, 133, 50
55, 47, 37
0, 5, 64, 45
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#212529
Shark
33, 37, 41
210, 11, 15
20, 10, 0, 84
About NewBridge Pharmaceuticals
NewBridge Pharmaceuticals is a leading brand in the healthcare industry, offering a wide range of products and services to meet the needs of patients and healthcare professionals. With a focus on therapy areas such as Gastroenterology, Genomics, Immunology, Neuroscience, Oncology/Hematology, and Rare Diseases, NewBridge is dedicated to providing innovative solutions that improve patient outcomes. At NewBridge, we believe in the power of collaboration, which is why we actively seek partnerships with like-minded organizations to further advance medical research and development.
Our dedicated team of professionals, including our experienced executive team and board of directors, ensures that we are at the forefront of medical advancements, consistently delivering high-quality products and services. Our in-house capabilities span across various departments, including Regulatory Affairs, Market Access, Medical Affairs, Sales & Marketing, Finance, Supply Chain & Logistics, Pharmacovigilance, Quality, Legal & Compliance, Information Technology, and Human Resources. This comprehensive approach allows us to provide holistic and effective solutions to our customers.
With our commitment to ethics and compliance, NewBridge adheres to the highest standards of business conduct, ensuring transparency and integrity in all our operations. Additionally, we offer an Early Access Program, enabling patients to access innovative therapies before they are widely available. To learn more about NewBridge Pharmaceuticals and our offerings, please visit our website or contact us directly.
We are dedicated to making a positive impact on healthcare worldwide
Company type
Privately Held
Year founded
2010
Company size
51-200 employees
